[Sponsored] Mayo Clinic physicians developed a clinical decision support tool to standardize care and improve care quality across Mayo Clinic. AskMayoExpert is the evolution of that work. The post The Evolution of a Clinical Decision Support Network appeared first on MedCity News.
“Almost 5 million able-bodied Medicaid recipients ‘simply choose not to work’ and ‘spend six hours a day socializing and watching television.’” Scott Jennings on “CNN NewsNight with Abby Phillip” on July 1 Republicans defended the GOP megabill’s Medicaid changes as targeting a group of people they believe shouldn’t qualify: people who can work but instead…
The cruel irony is that incredibly effective treatments already exist. Many people, however, cannot access them due to barriers to care The post A Massive Wave of Eye Disease is Coming, and Healthcare is Unprepared appeared first on MedCity News.
David Dyke is the Chief Product Officer of Relatient, which is one of the biggest players in the up and coming area of direct patient scheduling. As anyone who has been stuck in a phone tree or tried to reach a live human just to get an appointment at a doctor’s office knows, scheduling in…
As we confront the sobering statistics and growing impact of colorectal cancer, it’s clear that more education about the various options for testing is needed to increase screening rates across the U.S. The post A Closer Look at FIT Tests – A Primer on the Various Options for Colorectal Cancer Screening appeared first on MedCity News.
Many pandemic-era flexibilities around Medicare coverage of telehealth are due to expire in December 2024. There is bipartisan support for proposed legislation to extend these provisions for another two years, and Congress is weighing the potential benefits, risks, and costs of permanently expanding Medicare coverage of telehealth services. These FAQs provide answers to key questions…
Eli Lilly is licensing rights to a Phase 1-ready antibody that startup Alchemab developed for amyotrophic lateral sclerosis and other neurodegenerative disorders. Lilly’s pipeline has ALS drug candidates from previous deals with QurAlis and Verge Genomics. The post Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect appeared first on MedCity News.
LISTEN: A National Cancer Institute employee says cuts to research funding and a perceived lack of transparency at the agency are threatening the well-being of cancer patients. A spokesperson for the agency says that’s “misleading” — it’s working to make sure money is well spent. The National Cancer Institute, long credited with driving down U.S….
Aon Plc estimates U.S. employer healthcare costs to rise 9 percent in the coming year
In a resurvey of women voters three months later, KFF uncovered substantial shifts in favor of Vice President Harris across a range of key election issues, including the handling of rising household and health care costs as well as enthusiasm for the candidates and motivation to vote. As the presidential election draws near, the survey…